Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Invesco Mortgage Capital Inc (IVR), Two Harbors Investment Corp (TWO): Why Insiders Are Bullish on These High-Yielding Stocks?

Page 1 of 2

Since the launch of the third round of quantitative easing in September last year, the mortgage REITs sector has seen tremendous compression in profitability and dividend cuts. While there is no consensus on when these easing programs will end, the markets have started pricing it in. Given the mixed signals, mortgage REITs become an even more complicated investment decision. However, some insider buying makes it clear that the management is confident on the companies’ future. Top management has better insight and insider information to the growth prospects of the company, which is why insider buying is taken as a strong signal by the investor community.

This article features three such mortgage REITs that have reported recent insider buying, making me bullish on the stocks.

Diverse funding sources

Invesco Mortgage Capital Inc (NYSE:IVR) is one of the hybrid mortgage REITs because it has investments in both agency and non-agency mortgage-backed securities.

Invesco Mortgage Capital Inc (NYSE:IVR)

A discussion of agency and non-agency mortgage-backed securities is important because they are entirely different assets with entirely different behaviors. Agency mortgage-backed securities have the backing of government agencies like Freddie Mac. Since their principal and interest payments are guaranteed by the government, they are considered free of default or credit risk. On the other hand, non-agency don’t have the government backing and therefore are not default-free. This is exactly why they usually offer higher yields compared to agency paper. Their structure and the Fed’s involvement in the agency mortgage-backed securities markets make them behave very differently, providing the element of diversification.

Going forward, Invesco Mortgage Capital Inc (NYSE:IVR) seems to take full benefit of this diversification. Invesco Mortgage Capital Inc (NYSE:IVR)’s portfolio is constructed in such a way that it will benefit from a hike in interest rates. According to its most recent SEC filings, the company’s projected net interest income will increase 4.3% if the rates go up 50 basis points. Since the markets are already pricing in the Fed’s exit, the interest rates are on the rise. Therefore, I believe this is the time to make a move. Besides, the company has recently diversified its funding sources and added term-finance funding. This will create further benefit for the company in times of any disruption in the reposession markets.

My bullishness is also shared by the company’s top executives who have bought shares twice last week. The chief investment officer bought 2,100 shares on May 21 at an average price of $19.61. Before that, the CEO of the company bought 5,000 shares at an average price of $19.92. Remember these are not option exercises that are part of the executive compensation.

Diverse asset base

Two Harbors Investment Corp (NYSE:TWO) is another hybrid mortgage REIT with a diversified investment portfolio.The company invests in mortgage-backed securities to earn yields, while it also has investments in real estate from which it earns rental income. It reported that its projected net interest income would increase 6.6% if the rates go up 50 basis points.

Looking at the prevailing interest-rate environment, where the rates have started climbing, the insiders have started purchasing the company’s stocks. Five directors of the company have been reported to buy over 36,000 shares of the company at an average price of $11.56 per share during the month of May. Keep in mind the company’s stock is currently trading at $11.49 per share, which means this could be an entry point for you.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!